Apollomics Revenue

In the year 2025, Apollomics had annual revenue of $8.84M with 776.31% growth. Apollomics had revenue of $342.00K in the half year ending December 31, 2025, with 2.70% growth.

Revenue (ttm)

$8.84M

Revenue Growth

+776.31%

P/S Ratio

4.09

Revenue / Employee

$680,154

Employees

Market Cap

34.81M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.84M	7.83M	776.31%
Dec 31, 2024	1.01M	545.00K	117.46%
Dec 31, 2023	464.00K	-552.00K	-54.33%
Dec 31, 2022	1.02M	1.01M	50,700.00%
Dec 31, 2021	2.00K	-1.84M	-99.89%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Veru Inc.	16.89M
Evaxion	7.53M
CervoMed	4.01M
Pluri	1.34M
Werewolf Therapeutics	1.14M
Daré Bioscience	1.03M
Actinium Pharmaceuticals	90.00K

Revenue Rankings

APLM News

8 days ago - Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress - GlobeNewsWire
4 weeks ago - Apollomics Inc. Announces $2.0 Million Bridge Financing - GlobeNewsWire
4 months ago - Apollomics Reports First Half 2025 Financial Results - GlobeNewsWire
5 months ago - Apollomics Announces Settlement of Cayman Litigation - GlobeNewsWire
6 months ago - Apollomics Announces Changes to its Board of Directors and Composition of Committees - GlobeNewsWire
7 months ago - Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation - GlobeNewsWire
7 months ago - Apollomics, Inc. Company Operational Continuity Update - GlobeNewsWire
1 year ago - Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress - GlobeNewsWire

More News